ACE and peripheral neuropathy: Some preclinical data has revealed that RAS inhibitors, such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB), exert a neuroprotective effect in various murine models of peripheral neuropathy, potentially via angiotensin II type 2 receptor stimulation [9,10].